PubMed

Hypertriglyceridemic hyperapob: the unappreciated atherogenic dyslipoproteinemia in type 2 diabetes mellitus.

Sniderman AD, Scantlebury T, Cianflone K.

Ann Intern Med. 2001 Sep 18;135(6):447-59. Review.PMID: 11560458 [PubMed - indexed for MEDLINE]Related articlesFree article

Clinical relevance of the biochemical, metabolic, and genetic factors that influence low-density lipoprotein heterogeneity.

Kwiterovich PO Jr.

Am J Cardiol. 2002 Oct 17;90(8A):30i-47i. Review.PMID: 12419479 [PubMed - indexed for MEDLINE]Related articles

Hypertriglyceridemic hyperapoB in type 2 diabetes.

Sniderman AD, Lamarche B, Tilley J, Seccombe D, Frohlich J.

Diabetes Care. 2002 Mar;25(3):579-82.PMID: 11874951 [PubMed - indexed for MEDLINE]Related articlesFree article

[Diabetic dyslipoproteinemia]

Geiss HC, Parhofer K.

MMW Fortschr Med. 2006 Apr 6;148(14):30-3. German. PMID: 16669277 [PubMed - indexed for MEDLINE]Related articles

Beyond low-density lipoprotein: addressing the atherogenic lipid triad in type 2 diabetes mellitus and the metabolic syndrome.

Nesto RW.

Am J Cardiovasc Drugs. 2005;5(6):379-87. Review.PMID: 16259526 [PubMed - indexed for MEDLINE]Related articles

Does statin monotherapy address the multiple lipid abnormalities in type 2 diabetes?

Shepherd J.

Atheroscler Suppl. 2005 Sep;6(3):15-9. Review.PMID: 16046280 [PubMed - indexed for MEDLINE]Related articles

Atorvastatin treatment beneficially alters the lipoprotein profile and increases low-density lipoprotein particle diameter in patients with combined dyslipidemia and impaired fasting glucose/type 2 diabetes.

Pontrelli L, Parris W, Adeli K, Cheung RC.

Metabolism. 2002 Mar;51(3):334-42.PMID: 11887170 [PubMed - indexed for MEDLINE]Related articles

Abnormalities in lipoprotein metabolism in hemodialysis patients.

Königer M, Quaschning T, Wanner C, Schollmeyer P, Krämer-Guth A.

Kidney Int Suppl. 1999 Jul;71:S248-50.PMID: 10412790 [PubMed - indexed for MEDLINE]Related articles

Optimal management of combined dyslipidemia: what have we behind statins monotherapy?

Tenenbaum A, Fisman EZ, Motro M, Adler Y.

Adv Cardiol. 2008;45:127-53. Review.PMID: 18230960 [PubMed - indexed for MEDLINE]Related articles

The lipid triad in type 2 diabetes - prevalence and relevance of hypertriglyceridaemia/low high-density lipoprotein syndrome in type 2 diabetes.

Temelkova-Kurktschiev T, Hanefeld M.

Exp Clin Endocrinol Diabetes. 2004 Feb;112(2):75-9. Review.PMID: 15031770 [PubMed - indexed for MEDLINE]Related articles

Dose-dependent action of atorvastatin in type IIB hyperlipidemia: preferential and progressive reduction of atherogenic apoB-containing lipoprotein subclasses (VLDL-2, IDL, small dense LDL) and stimulation of cellular cholesterol efflux.

Guerin M, Egger P, Soudant C, Le Goff W, van Tol A, Dupuis R, Chapman MJ.

Atherosclerosis. 2002 Aug;163(2):287-96.PMID: 12052475 [PubMed - indexed for MEDLINE]Related articles

Statins and diabetes.

Carmena R, Betteridge DJ.

Semin Vasc Med. 2004 Nov;4(4):321-32. Review.PMID: 15861314 [PubMed - indexed for MEDLINE]Related articles

Low-density lipoprotein size and subclasses are markers of clinically apparent and non-apparent atherosclerosis in type 2 diabetes.

Berneis K, Jeanneret C, Muser J, Felix B, Miserez AR.

Metabolism. 2005 Feb;54(2):227-34.PMID: 15690318 [PubMed - indexed for MEDLINE]Related articles

Effects of insulin resistance and type 2 diabetes on lipoprotein subclass particle size and concentration determined by nuclear magnetic resonance.

Garvey WT, Kwon S, Zheng D, Shaughnessy S, Wallace P, Hutto A, Pugh K, Jenkins AJ, Klein RL, Liao Y.

Diabetes. 2003 Feb;52(2):453-62.PMID: 12540621 [PubMed - indexed for MEDLINE]Related articlesFree article

Peroxisome proliferator-activated receptor-gamma agonist increases both low-density lipoprotein cholesterol particle size and small high-density lipoprotein cholesterol in patients with type 2 diabetes independent of diabetic control.

Bavirti S, Ghanaat F, Tayek JA.

Endocr Pract. 2003 Nov-Dec;9(6):487-93.PMID: 14715475 [PubMed - indexed for MEDLINE]Related articles

[Relation between insulin resistance and small, dense lipoproteins with low density and the development of atherosclerosis in type 2 diabetes mellitus]

Fábryová L, Cagán S.

Bratisl Lek Listy. 1998 Mar-Apr;99(3-4):138-45. Review. Slovak. PMID: 9919742 [PubMed - indexed for MEDLINE]Related articles

Regulation of plasma triglycerides in insulin resistance and diabetes.

Ginsberg HN, Zhang YL, Hernandez-Ono A.

Arch Med Res. 2005 May-Jun;36(3):232-40. Review.PMID: 15925013 [PubMed - indexed for MEDLINE]Related articles

Intensive insulin therapy reduces small dense low-density lipoprotein particles in patients with type 2 diabetes mellitus: relationship to triglyceride-rich lipoprotein subspecies.

Hayashi T, Hirano T, Yamamoto T, Ito Y, Adachi M.

Metabolism. 2006 Jul;55(7):879-84.PMID: 16784958 [PubMed - indexed for MEDLINE]Related articles

[Diabetic dyslipoproteinemia: physiopathological bases and treatment prospects]

Demant T.

Fortschr Med Orig. 2001;119(1):37-40. German. PMID: 11935656 [PubMed - indexed for MEDLINE]Related articles

Management of hypercholesterolaemia in the patient with diabetes.

Packard C, Olsson AG.

Int J Clin Pract Suppl. 2002 Jul;(130):27-32. Review.PMID: 12296606 [PubMed - indexed for MEDLINE]Related articles